Recombinate and Trastuzumab-dkst
Determining the interaction of Recombinate and Trastuzumab-dkst and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Recombinate-Trastuzumab-dkst Intravenous
- Recombinate-Trasylol
- Recombinate-Travasol
- Recombinate-Travatan
- Recombinate-Travatan Z
- Recombinate-Travatan Z Ophthalmic Solution
- Trastuzumab-dkst-Recombinate recombinant
- Trastuzumab-dkst-Recombivax
- Trastuzumab-dkst-Recombivax HB
- Trastuzumab-dkst-Recombivax HB Adult
- Trastuzumab-dkst-Recombivax HB Dialysis Formulation
- Trastuzumab-dkst-Recombivax HB Pediatric/Adolescent